METHODOLOGY
Participants: ALL survivors attending the Pediatric Cancer Survivorship Clinic (PCSC) were enrolled after a written informed consent. The study was performed between July 2016 to November 2017. A total of 70 survivors of ALL were recruited. The institutional review board of All India Institute of Medical Sciences(AIIMS), approved the study protocol. Eligibility criteria included survivors of ALL, aged 6-17 years who had completed treatment and had a documented remission of atleast 2 years. Exclusion criteria included history of any central nervous system(CNS) or sensory-motor deficits during treatment, concurrent neurological or psychiatric disorder not primarily attributed to ALL or any previous genetic diagnosis with known association with neurocognitive impairment(eg., Down syndrome).